Former US President Donald Trump has announced plans to impose tariffs on pharmaceutical products, with the initial levy expected to be introduced by the end of July 2025. Trump indicated that the tariffs will start at a low rate, allowing pharmaceutical companies approximately one to one and a half years to establish or expand domestic manufacturing capacity before the tariffs increase to a high rate, potentially up to 200%. He also mentioned that tariffs on semiconductors could follow shortly after the pharmaceutical tariffs are implemented. Trump emphasized that the US would coordinate with the United Kingdom on pharmaceutical matters and clarified that the tariffs would not be used as a trade barrier against the UK. These measures are part of a broader strategy to encourage pharmaceutical manufacturing in the United States.